drugset / Trial / NCT02304055

Carbetocin Versus Oxytocin in the Management of Atonic Post Partum Haemorrhage (PPH) in Women Delivered Vaginally: A Randomised Controlled Trial

NCT02304055

Phase 3 Completed 100 enrolled Cairo University
RandomizedParallel-groupTriple-blindTreatment

Summary

200 women will be randomly divided into 2 equal groups using computer generated random numbers. Group 1 will receive Carbetocin 100 µgm (Pabal® Ferring, UK) and group 2 will receive oxytocin 5IU (Syntocinon®, Novartis, Switzerland).

Timeline

Start
2013-05
Primary completion
2014-12
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Carbetocin Peptide 100 ug Intravenous
Comparator Oxytocin Peptide 5 iu Intravenous

Indications